Johnson & Johnson (BIT:1JNJ)

Market Cap	333.71B
Revenue (ttm)	82.47B
Net Income (ttm)	20.13B
Shares Out	n/a
EPS (ttm)	8.29
PE Ratio	16.57
Forward PE	n/a
Dividend	4.62 (3.33%)
Ex-Dividend Date	Feb 17, 2025

Volume	113
Average Volume	222
Open	135.12
Previous Close	136.02
Day's Range	135.06 - 139.14
52-Week Range	128.30 - 162.26
Beta	n/a
RSI	43.01
Earnings Date	Apr 15, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD